2022
DOI: 10.1016/j.ctro.2022.07.003
|View full text |Cite
|
Sign up to set email alerts
|

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 37 publications
0
2
0
Order By: Relevance
“…The study of the effects of radiotherapy on WM microstructure alterations and their translation into cognitive and motor deficits represent an expanding field of neuro-oncology research [123,124]. Beyond the preservation of essential cortical structures such as the hippocampus [125,126], it is now essential that future guidelines integrate current knowledge on LGG-induced plasticity and functional data obtained from awake surgery to adapt treatment planification. Modulations of therapeutic targets and multistage irradiations accounting for histomolecular data (e.g., MGMT status, 1p19q codeletion) and intrasurgical findings (critical functional WM tracts) may help to optimize the onco-functional balance and to delay cognitive declines [127].…”
Section: Radiotherapymentioning
confidence: 99%
“…The study of the effects of radiotherapy on WM microstructure alterations and their translation into cognitive and motor deficits represent an expanding field of neuro-oncology research [123,124]. Beyond the preservation of essential cortical structures such as the hippocampus [125,126], it is now essential that future guidelines integrate current knowledge on LGG-induced plasticity and functional data obtained from awake surgery to adapt treatment planification. Modulations of therapeutic targets and multistage irradiations accounting for histomolecular data (e.g., MGMT status, 1p19q codeletion) and intrasurgical findings (critical functional WM tracts) may help to optimize the onco-functional balance and to delay cognitive declines [127].…”
Section: Radiotherapymentioning
confidence: 99%
“…However, the current comprehensive treatment has certain side effects, such as incomplete removal by surgery, destruction of functional areas, and indiscriminate killing of normal nerve cells and glioma cells by radioactive elements during radiation therapy [20,21]. Chemotherapy, in contrast, is not only limited by the drug tolerance of glioma (e.g., platinum-based chemotherapeutic agents, a class of chemotherapeutic agents that affect the cell cycle, are not effective, because gliomas are resistant to platinum-based drugs [22]) but also decreases neurocognitive and other functions [23,24].…”
Section: Introductionmentioning
confidence: 99%